Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedAn NIH grant/contract line (2014 ( U.S. NIH Grant/Contract )) was added to the study's external identifiers. This addition provides an explicit funding reference associated with the trial.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of the previous v3.6.4, indicating a minor site-release update.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform-level update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.6.3 is now shown, replacing v3.6.0. This reflects a backend update to the site rather than changes to the study details.SummaryDifference0.0%

- Check75 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label; recruitment status now states 'No longer looking for participants', and the page revision is updated to v3.6.0.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated the page version from v3.5.4 to v3.5.5. This reflects a small update to the page without changing the study details or other visible content.SummaryDifference0.0%

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.